Lexicon earns third $10M milestone from Novo Nordisk for LX9851

August 24, 2026 8:30 AM

Lexicon Pharmaceuticals (Nasdaq: LXRX) announced it has earned a third $10 million milestone payment in 2026 from Novo Nordisk A/S ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found